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Purpose: To understand the role of TGF-β related signals in the repair of a corneal endothelium defect and also to evaluate
the therapeutic effect of Smad7 gene transfer on injury induced fibrosis of the corneal endothelium in rats.
Methods: (1) Japanese albino rabbits (n=108) were used. Blocks of central cornea (4×4 mm) were prepared. After partially
scraping the endothelium to produce a defect, the blocks were organ cultured for 24 h in the presence of either exogenous
growth factors, transforming growth factor β (TGF-β)-neutralizing antibody, or inhibitors of each TGF-β related signal.
Endothelium repair was assayed under light microscopy. (2) Adult Wistar rats (n=62) were then used. Smad7 expressing
adenoviral vector (Smad7-Ad) or non-functioning control vector (Cre-Ad) was administered to the anterior chamber of
an eye. The cornea was burned with topical 1 N NaOH (10 μl) three days later. After specific intervals, the eye was
histologically observed.
Results: (1) The endothelial layer that elongated toward the defect lacked proliferation after 24 h in organ culture.
Endogenous TGF-β was required for endothelium defect repair. Inhibition of p38 and Erk but not c-Jun NH2-terminal
kinase (JNK) and ALK5 signal (Smad) retarded such cell spreading. (2) Adenoviral Smad7 overexpression suppressed
fibrogenic reaction of the endothelium of an alkali-burned cornea as evaluated by immunohistochemistry for phospho-
Smad2, collagen I, and α-smooth muscle actin, a marker for endothelial-mesenchymal transition (EnMT), and by electron
microscopy.
Conclusions: Inhibition of Smad and JNK signals do not affect corneal endothelium defect repair. Inhibition of Smad
suppresses fibrogenic reaction via EnMT of corneal endothelium in vivo.
A healthy endothelium is essential for the maintenance
of  corneal  homeostasis  and  transparency  of  the  cornea.
Defects in the endothelium are repaired mainly by cell size
enlargement and cell migration in humans, and additional cell
proliferation also participates in such repair in rodents.
An  alkali  burn  in  the  cornea  is  a  clinically  serious
condition because it damages not only the epithelium and
stroma but also the endothelium. During healing after an alkali
burn, the fibrous structure is formed in the endothelial layer
beneath  Descemet’s  membrane  [1-3].  Formation  of  such
fibrous  structure  impairs  the  physiologic  function  of  the
endothelium  to  maintain  transparency.  In  the  process  of
fibrogenic  reaction,  corneal  endothelial  cells  undergo
epithelial/endothelial mesenchymal transition (EMT/EnMT)
and transform to fibrogenic myofibroblasts [4-7]. EMT serves
as the pathogenesis of fibrotic diseases in many tissues such
as the eye lens, retinal pigment epithelium, kidney, liver, and
lungs [8-12]. EMT is modulated by a set of various growth
factors/cytokines.  Among  them,  it  is  believed  that
transforming growth factor β (TGF-β) is one of the most
potent growth factors involved in myofibroblast generation
Correspondence  to:  Takayoshi  Sumioka,  MD,  Department  of
Ophthalmology, Wakayama Medical University, 811-1 Kimiidera,
Wakayama,  641-0012,  Japan;  Phone:  81-73-447-2300;  FAX:
81-73-448-1991; email: sumioka@wakayama-med.ac.jp
through EMT [13-15]. Indeed, in many tissues, blocking TGF-
β signaling by targeted deletion of Smad3 or gene introduction
of Smad7, an inhibitory Smad, reportedly prevents EMT and
pathological tissue fibrosis. Thus, blocking TGF-β signaling
or  introducing  Smad7  is  of  therapeutic  value  [16-19].
However, it is not fully examined if an interfering TGF-β
signal modulates EMT of corneal endothelial cells and also
exhibits a therapeutic effect.
TGF-β activates not only Smad signals but also other
cytokines/growth factors such as mitogen-activated protein
kinase (MAPK), p38MAPK, and c-Jun NH2-terminal kinase
(JNK) [20-22]. Because migration is a major component of
wound  healing  in  the  corneal  endothelium,  strategies  of
inhibition of unfavorable EMT of the corneal endothelium is
not to be accompanied with an impairment of cell migration.
In the present study, we first examined which TGF-β
related cytoplasmic signaling is essential for the repair of a
defect in the corneal endothelium in organ culture, and then
we investigated if a Smad7 gene transfer exhibits a therapeutic
effect on injury induced fibrogenic reaction of the corneal
endothelium. It is required to know the role of each TGF-β
related signal in endothelial cell repair to avoid inhibition of
the cell migration promoting signal when we try to block
unfavorable EnMT by targeting TGF-β related signal(s).
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Experiments  were  approved  by  the  DNA  Recombination
Experiment  Committee  and  the  Animal  Care  and  Use
Committee of Wakayama Medical University (Wakayama,
Japan)  and  were  conducted  in  accordance  with  the
Association  for  Research  in  Vision  and  Ophthalmology
Statement for the Use of Animals in Ophthalmic and Vision
Research.
Migration of corneal endothelial cells in organ culture:
First,  Japanese  albino  rabbits  (n=108)  were  used.  After
sacrificing, the central cornea was excised. Blocks of the
cornea (4 mm×4 mm) were prepared. The endothelium was
partially (approximately 50%) removed by scraping with a
glass coverslip as shown in Figure 1A. The endothelium of
the corneal periphery was preserved. The cornea block with a
endothelial defect was then organ cultured for 24 h in serum-
free Dulbecco’s modified Eagle medium supplemented with
antibiotics and an antimycotic in the presence or absence of
each  reagent.  Reagents  added  to  the  medium  were
recombinant human epidermal growth factor (EGF, 10.0 ng/
ml; R&D systems, Minneapolis, MN), human TGF-β1 (1.0
ng/ml;  R&D  systems),  human  TGF-β2  (1.0  ng/ml;  R&D
systems), EGF (10.0 ng/ml) plus TGF-β1 (1.0 ng/ml), EGF
(10.0 ng/ml) plus TGF-β2 (1.0 ng/ml), a p38MAPK inhibitor
called SB203580 (10 μM; Sigma-Aldrich, St Louis, MO), a
MAPK  inhibitor  called  U0126  (10  μM;  Calbiochem,  San
Diego, CA), a JNK inhibitor (5 μM; Calbiochem), and a ALK5
inhibitor called SB431542 (10 μM; Sigma-Aldrich). After
being cultured for 24 h, the corneal blocks were stained with
0.2% Alizarin red and 0.25% trypan blue, and the endothelium
was observed under light microscopy. The distance between
the line of the original defect margin and the spreading tip of
the newly migrating endothelium was measured and served as
the  endothelium  migration.  Immunohistochemistry  for
proliferating nuclear cell antigen (PCNA) was performed to
examine if the cell spreading (or healing) of the endothelium
was associated with cell proliferation during the 24 h period
(Figure 1B). Specificity of the inhibitory effect of SB431542
on Smad2/3 signaling was established [23]. To examine the
role  of  endogenous  TGF-β  in  endothelium  spreading,  the
medium was supplemented with either mouse monoclonal
anti-human TGF-β neutralizing antibody (20 μg/ml, R&D
systems) or mouse IgG1 derived from BALB/c strain (20 μg/
ml, Sigma-Aldrich).
Smad7  gene  transfer  using  a  Cre/LoxP  adenoviral
vector: Here, adult Wistar rats (n=4) were used. Efficacy of
gene transfer by this system was initiated by using adenoviral
vectors carrying CAG (cytomegalovirus enhancer, chicken
β-actin promoter plus a part of the 3′ untranslated region of
rabbit β-globin) promoter driven Cre recombinase (Cre-Ad)
and  LoxP-neomycin  resistance  gene-LoxP  (LNL)-green
fluorescein protein (GFP) expressing vector. The cryosection
(7 μm thick) of the treated cornea was prepared and observed
under fluorescent microscopy as previously reported [24].
Adult  Wistar  rats  (n=12)  were  again  used  for  the
adenoviral gene transfer. Adenoviral gene transfer of mouse
Figure 1. Method for assaying spreading
of  the  endothelial  cell  sheet  in  organ
culture. A: After 24 h culture, the length
of the endothelium path on the denuded
area was measured. B: The spreading
sheet  of  the  endothelial  cells  lacks
proliferating  cell  nuclear  antigen
(PCNA) at 24 h in the control culture.
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2273Smad7 cDNA was performed by using the Cre/LoxP system
of the adenoviral vector (Takara, Tokyo, Japan) as previously
reported by us [24]. The viral vector (2.0×104 PFU/ml, either
Cre-Ad  alone  or  a  mixture  of  Cre-Ad  and  LNL-Smad7-
expressing vector [Smad7-Ad]) was mixed with 2.0 μl of
hyaluronan  (OPEGAN®,  Santen  Pharmaceutical,  Osaka,
Japan) and injected into the anterior chamber of one eye in
each rat. After three days, one week, and two weeks, the
animals were killed at each time period and the corneas were
excised. Cre recombinase expressed by Cre-Ad deletes the
LoxP site of the stuffer in the promoter region of the LNL-
Smad7-Ad, and thus, Smad7 mRNA is expressed. Total RNA
was extracted by using Sigma GenElutedTM Mammalian Total
RNA Miniprep Kit (Sigma-Aldrich) and processed for real-
time reverse transcription polymerase chain reaction (RT–
PCR) for Smad7 mRNA as previously reported by us [24].
The cornea was also processed for immunohistochemistry for
Smad7 as previously reported [24].
Cornea  alkali  burn  model  of  corneal  endothelium
fibrosis: Adult Wistar rats (n=46) were used here as well. The
viral vector (either Cre-Ad or Smad7-Ad) in hyaluronan was
injected into the anterior chamber of an eye of each rat. After
three days, 10 μl of 1.0 N NaOH was topically applied to the
cornea, and ofloxacin ointment was administered to reduce
the  risk  of  bacterial  contamination.  After  three  days,  one
week, and two weeks, the animals were killed at each time
period by an overdose of pentobarbital, i. p., and the eye was
enucleated, fixed with 4% paraformaldehyde, and embedded
in paraffin (n=38) as previously reported [24]. Deparaffinized
sections  (5  µm  thick)  were  processed  for
immunohistochemistry  for  phospho-Smad2,  α-smooth
muscle actin (myofibroblast marker), type I collagen, and
PCNA. Eight corneas of each group at week 1 post-alkali burn
Figure 2. Effects of exogenous EGF, TGF-β1, or TGF-β2 on the
spreading of the corneal endothelium in organ culture. Exogenous
EGF promoted endothelium spreading. While adding exogenous
TGF-β1 (A) or TGF-β2 (B) to the medium exhibited no effect on
endothelium  sheet  elongation,  it  counteracted  the  promotion  of
endothelial sheet elongation by exogenous EGF.
were fixed in 2% glutaraldehyde in 0.1 M phosphate buffer.
The  samples  were  dehydrated  though  a  graded  series  of
ethanol and a critical point dryer. After coating with gold by
using  ion  spatter,  the  endothelium  was  observed  under
scanning electron microscopy.
RESULTS
Endothelium migration and cytokine signaling: After a 24 h
incubation, the endothelium defected corneal block lacked
PCNA  labeled  endothelium  (Figure  1B),  and  thus,  later
elongation  of  the  endothelium  toward  the  defect  was
performed by cell migration during the first 24 h in organ
culture. Exogenous EGF promoted endothelium repair. While
adding  exogenous  TGF-β1  or  TGF-β2  to  the  medium
exhibited  no  effect  on  endothelium  sheet  spreading,  it
counteracted the promotion of the endothelial sheet spreading
by exogenous EGF (Figure 2).
The role of endogenous TGF-β was evaluated by using a
neutralizing antibody. Adding the neutralizing anti-TGF-β
Figure 3. The role of endogenous TGF-β was evaluated by using
neutralizing  antibody.  Adding  neutralizing  anti-TGF-β  antibody
retarded endothelium repair.
Figure 4. Roles of TGF-β related signaling on the spreading of the
corneal endothelium in organ culture. The p38 inhibitor, SB203580,
and  the  MAPK  inhibitor,  U0126,  hindered  endothelium  sheet
elongation  (inhibition:  SB203580>U0126).  Neither  the  JNK
inhibitor nor the ALK5 inhibitor, SB431542, (blocking Smad2/3
signal) have a significant effect on its repair.
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2274antibody retarded endothelium repair (Figure 3). As for the
roles  of  TGF-β  related  signaling,  specific  inhibitors  were
used. The p38 inhibitor, SB203580, and the MAPK inhibitor,
U0126,  hindered  endothelium  sheet  spreading  (inhibition:
SB203580>U0126; Figure 4). Neither the JNK inhibitor nor
the ALK5 inhibitor, SB431542, (thus blocking the Smad2/3
signal) had a significant effect on its repair (Figure 4).
Smad7 gene transfer by using Cre/LoxP adenoviral vector:
Before examining if the introduction of exogenous mouse
Smad7 cDNA leads to its mRNA expression, we observed the
expression  of  exogenous  GFP  by  using  fluorescent
microscopy. In an unfixed cryosection, exogenous GFP was
observed in the endothelial layer of a cornea treated with Cre-
Ad and LNL-GFP-Ad very faintly at day 3 (Figure 5B) and
obviously at week 1 (Figure 5D, arrows) while it was not seen
in eyes with just Cre-Ad (Figure 5A,C).
Then we examined the expression of Smad7 mRNA in
Smad7-Ad  treated  corneas  by  real-time  RT–PCR  and
immunohistochemistry (Figure 5E). Mouse Smad7 mRNA
was detected at a high level in Smad7-Ad corneas as early as
day 3 and lasted until week 2 but never in a control rat cornea.
Immunohistochemistry  showed  high,  intense
immunoreaction of Smad7 at week 1 as shown in Figure 5G.
Cornea alkali burn model of corneal endothelium fibrosis:
Alkali  exposure  resulted  in  an  epithelial  defect,  stromal
opacity  (inflammation  and  neovascularization),  and
inflammation in the anterior chamber as previously reported
[25]. However, these pathological findings were overall less
severe in the Smad7-Ad group when compared to the control
Cre-Ad group at each time point (Figure 6).
As for the endothelium, HE staining histology showed
that  there  was  abnormal  accumulation  of  fibrous  tissue
(asterisk) posterior to Descemet’s membrane at day 3, week
1, and week 2 in the eyes of the control Cre-Ad group (Figure
7A,C,E) while such findings were not observed in the Smad7-
Ad group eyes at each time point (Figure 7B,D,F).
Immunohistochemistry first showed that the cells in the
fibrous tissue in the control eyes were labeled for nuclear
phospho-Smad2 at each time point while not seen in eyes of
the Smad7-Ad group (Figure 8), indicating that exogenous
Smad7 might block Smad signaling. The cells in the fibrous
tissue in the control eyes were labeled for αSMA, the marker
of myofibroblast or EnMT, while this marker was not seen in
the eyes of the Smad7-Ad group (Figure 9). Type I collagen
was stained as a marker of fibrous matrix accumulation. Type
I collagen was detected in the matrix of fibrous tissue formed
in eyes of the control group (Figure 9). Nuclear staining of
PCNA was more prominent in an eye of the Smad7-Ad group
as compared with an eye of the Cre-Ad group (Figure 9). Such
Figure 5. Efficacy of gene transfer by using Cre/LoxP adenoviral vector. A-D: In an unfixed cryosection, exogenous green fluorescein protein
(GFP) was observed in the endothelial layer of a cornea treated with Cre-Ad and LNL-GFP-Ad very faintly at day 3 (B) and obviously at
week 1 (D, arrows) while it was not seen in the eyes with just Cre-Ad (A,C). Bar, 10 μm. E: Mouse Smad7 mRNA was detected at a high
level in Smad7-Ad corneas as early as day 3 and lasted until week 2 but was never detected in the control rat cornea. F-G: Immunohistochemistry
showed high intense immunoreaction of Smad7 in the endothelium of a cornea in the Smad7-Ad group (G), but this was not seen in a control,
Cre-Ad treated cornea (F). Bar, 50 μm.
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2275a difference of PCNA staining was not seen between the
groups at day 3 or at week 2 (data not shown).
Scanning  electron  microscopy  showed  that  the  inner
surface of the cornea was occupied with elongated cells of a
fibroblast-like morphology in an eye of the control group at
week 1 (Figure 10A). On the other hand, in an eye of the
Smad7-Ad group, the inner corneal surface was found to be
covered with enlarged flattened cells with a central nuclear
elevation (arrows) in association with adhesion of spheroid
cells in the central corneal zone and also to be covered with
relatively normal-like endothelial cells with a clear cell-cell
Figure 6. Cornea alkali burn model in
rats.  Alkali  exposure  resulted  in  an
epithelial defect, stromal opacity, and
hemorrhaging in the anterior chamber.
These  pathological  findings  were
overall  less  severe  in  the  Smad7-Ad
group  (B,D)  as  compared  with  the
control Cre-Ad group (A,C) at day 3
(A,B) and week 1 (C,D).
Figure 7. Hematoxylin and eosin staining of the corneal endothelium during healing after alkali exposure. Histology showed that there was
abnormal accumulation of fibrous tissue (asterisk) posterior to the Descemet’s membrane at day 3 (A), week 1 (C), and week 2 (E) in the eyes
of the control Cre-Ad group while such findings were not observed in the eyes of the Smad7-Ad group at each time point (B,D,F). Inflammation
in the stroma was also less severe in a Smad7-Ad treated cornea compared to a control cornea at day 3. Bar, 50 μm.
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2276contact, although the cells did not exhibit a hexagonal shape
(Figure 10B,C).
DISCUSSION
We first examined the roles of cytokines/growth factors and
their signals in the healing of the corneal endothelium in organ
culture. In a 24 h culture, the cell spreading of the endothelial
sheet toward the defect lacked PCNA staining, and thus, cell
migration was the main component of defect repair in this
experimental system. We then showed that endothelial repair
after producing a defect was accelerated by exogenous EGF,
and this acceleration was counteracted by the further addition
of  exogenous  TGF-β1/2.  However,  endogenous  TGF-β  is
considered  to  be  essential  to  endothelial  migration  as  the
neutralizing  antibody  retarded  the  endothelial  sheet
spreading. Endogenous TGF-β secreted by endothelium or by
both the endothelium and keratocytes is considered to be
required for endothelium migration in that the neutralizing
antibody retarded its migration. We consider that endogenous
TGF-β  was  enough  to  affect  endothelium  migration  and
further addition of exogenous TGF-β1/2 did not do anything.
In the present study, EGF was used as one of the major growth
factors that reportedly promote cell migration in an injured
tissue. However, endogenous TGF-β might not be enough to
counteract  an  EGF-mediated  promotion  of  cell  migration.
However, this EGF action was considered to be blocked by a
large amount of TGF-β1/2 added to the culture medium. We
then had to detect the role of each TGF-β related signal in
endothelial spreading/migration before we planned an in vivo
gene transfer experiment that targets TGF-β driven EnMT and
subsequent fibrogenic reaction in the corneal endothelium. It
was required to prevent the inhibition of spreading/migration-
promoting signal when we tried to block EnMT by targeting
TGF-β related signals. The results showed that the p38 and
Erk signals were involved in endothelial defect repair (mainly
by cell migration) while Smad and JNK had minimal roles in
it. Our previous study showed that myofibroblast generation
by epithelial types depend on Smad and/or p38 both in vitro
and in vivo [17-19,26]. Smad7 is an inhibitory Smad molecule
that blocks TGF-β activated Smad2/3 signal. Injury induced
tissue fibrosis in the crystalline lens or fibrosis in the retinal
pigment  epithelium  after  producing  experimental  retinal
detachment were prevented by the adenoviral gene transfer of
Smad7 or dominant-negative p38MAPK in mice [17-19,26].
p38  signaling  reportedly  phosphorylates  the  middle-linker
region of Smad2/3 molecules but not the classical COOH-
terminal  region  of  Smad2/3  [27,28].  Our  previous
experiments showed that p38-mediated phosphorylation of
the  Smad  middle  linker  region  is  required  for  the  full
activation  of  Smad  dependent  gene  expression  in  retinal
pigment epithelial cells but not in fibroblasts in vitro [26].
However, our present study clearly showed that the inhibition
of p38 is unfavorable for the purpose of promoting endothelial
repair. These reports also encouraged us to use Smad7 gene
transfer to promote endothelial healing after an alkali burn by
inhibiting myofibroblast generation and fibrogenic reaction in
the corneal endothelium.
Figure 8. Expression pattern of phospho-Smad2 in healing endothelium of an alkali-burned cornea. Immunohistochemistry showed that the
cells in the fibrous tissue in the control eyes were labeled for nuclear phospho-Smad2 at day 3 (A) and the number of such labeled cells
increased in the fibrous tissue that formed posterior to Descemet’s membrane at week 1 (C) and week 2 (E). Phopsho-Smad2 positive cells
were not seen in the endothelial layer of Smad7-Ad eyes at each time point (B,D,F). The finding indicates that exogenous Smad7 might block
Smad signaling. Bar, 50 μm.
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2277We  therefore  tried  to  suppress  an  injury-induced,
unfavorable fibrogenic reaction of corneal endothelial cells in
vivo by Smad7 gene introduction. We employed the Cre/LoxP
system  of  adenoviral  gene  transfer  of  Smad7  that  blocks
phosphorylation of TGF-β driven Smad2/3 activation.
Indeed,  Smad7  overexpression  suppressed  an  injury-
induced fibrogenic reaction of the corneal endothelium in vivo
in rats. Expression of αSMA and the accumulation of collagen
I  were  almost  completely  abolished  with  Smad7
overexpression. Thus, injury-induced EnMT and subsequent
endothelial fibrosis was blocked by Smad7. Phospho-Smad2
labeled cell nuclei were much less observed, which means that
overexpressed Smad7 acted to block the Smad signal. We also
observed an increase in cell proliferation in the endothelium
Figure 9. Expression pattern of a marker for endothelial-mesenchymal transition, α-smooth muscle actin, and that for fibrogenic reaction, type
I collagen, as well as PCNA in the healing, post-alklai burn, endothelium. The cells in the fibrous tissue posterior to Descemet’s membrane
in the control eyes were labeled for αSMA, the marker of myofibroblast or EnMT, as early as day 3 (A, arrows; compare to B). The cells in
such a fibrous structure were markedly labeled at week 1 (C) and week 2 (E). Such labeled cells were not seen in the corneas of the Smad7-
Ad group throughout the intervals of healing. Stromal cells exhibited positive αSMA at week 2 (F). Type I collagen was stained as a marker
of fibrous matrix accumulation. In the eyes of the control group, type I collagen was detected in the matrix of fibrous tissue formed at week
1 (F) and week 2 (K) but not at day 3. No type I collagen immunoreactivity was observed posterior to the Descemet’s membrane in the eyes
of the Smad7-Ad group throughout the intervals (H,J,L). Nuclear staining of PCNA was more prominent in an eye of the Smad7-Ad group
(N) than in an eye of the Cre-Ad group (M). Such a difference of PCNA staining was not seen between the groups at day 3 or at week 2 (data
not shown). Bar, 50 μm.
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2278as detected by PCNA immunoreactivity. Blocking TGF-β/
Smad signaling might in turn accelerate cell proliferation. The
mechanism of promoting cell proliferation by blocking Smad
signaling might be speculated with in vitro studies. It was
reported that TGF-β/Smad inhibits epithelial cell growth in
part via transcriptional induction of the cell cycle inhibitor,
p21  (WAF1/Cip1;  p21).  A  pancreatic  cancer  cell  line
engineered to overexpress Smad7 are resistant to the actions
of TGF-β1 with respect to growth inhibition and cisplatin-
induced  apoptosis.  Smad7  overexpression  interfered  with
TGF-β1 mediated attenuation of cyclin A and B levels, the
inhibition of cdc2 dephosphorylation and cyclin dependent
kinase 2 (CDK2) inactivation, upregulation of p27, and the
maintenance  of  the  retinoblastoma  protein  in  a
hypophosphorylated state [29,30] Moreover, opacification of
the corneal stroma also seemed less in the Smad7-Ad group
as  compared  with  the  control  group,  suggesting  that  the
promotion of endothelial repair might be beneficial in the
restoration of homeostasis in a whole cornea.
It was reported that fibroblast growth factor 2 (FGF-2)
promotes  EnMT  via  activation  of  phosphatydil  inositol-3
(PI-3) kinase like other epithelial cell types, i. e., a renal
tubular epithelial cell [6,31,32]. Moreover, FGF-2 performs
an additional promotion of TGF-β driven EnMT or epithelial-
mesenchymal transition (EMT) in a renal tubular epithelial
cell or cancer cells. Thus, signaling pathways toward EnMT
or EMT originated from TGF-β and FGF-2, and they may be
independent of each other.
In conclusion, blocking Smad signaling has a minimal
effect on the repair of a defect in the corneal endothelium and
also  Smad7  gene  transfer  effectively  suppresses  injury-
induced fibrogenic reaction in the corneal endothelium. We
Figure 10. Morphology of the endothelial surface as observed by scanning electron microscopy. Ultrastructurally, the inner surface of the
cornea was occupied with elongated cells of a fibroblast-like morphology in an eye of the control group at week 1 (A). On the other hand, in
an eye of the Smad7-Ad group, the inner corneal surface was found to be covered with enlarged flattened cells with a central nuclear elevation
(arrows) in association with adhesion of spheroid cells in the central corneal zone (B). The inner corneal surface was also to be covered with
relatively normal-like endothelial cells with a clear cell-cell contact, although the cells did not exhibit a hexagonal shape (C). Bar, 10 μm.
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2279have previously reported that natural constituents of an herbal
medicine  exhibit  anti-Smad  effects  in  vitro  and  also
therapeutic effects in the treatment of tissue fibrosis in the
liver or cornea in vivo. The finding indicates that blocking
Smad2/3  signaling  irrespective  the  methods  might  be
effective in the treatment of corneal endothelial fibrosis.
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